Seeking Alpha

JNJ's Janssen Biotech unit requests FDA approval of Simponi, its investigational intravenous...

JNJ's Janssen Biotech unit requests FDA approval of Simponi, its investigational intravenous formulation for the treatment of adults with moderately to severely active rheumatoid arthritis.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector